Charles River (NYSE: CRL) director exercises options, sells stock at $300
Rhea-AI Filing Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) director James C. Foster reported an option exercise-and-sale transaction in the company’s common stock. On August 25, 2026, he exercised stock options covering 33,561 shares of common stock at exercise prices of $194.12 and $208.44 per share, receiving the underlying shares.
On the same date, he sold 33,561 shares of common stock at $300.00 per share in an open market or private transaction. According to the filing, this exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan initially adopted on March 6, 2026. Following these transactions, Foster also reports indirect holdings of common stock through several trusts and Grantor Retained Annuity Trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 33,561 shares ($3.38M approx. pre-tax spread)
Exercise and Sale
10 txns
Insider
FOSTER JAMES C
Role
Director
Sold
33,561 shs ($10.07M)
Approx. gross sale proceeds
$10.07M
Approx. exercise cost
$6.69M
Approx. pre-tax spread
$3.38M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 21,132 | $0.00 | $0.00 |
| Exercise | Stock Options (Right to Buy) | 12,429 | $0.00 | $0.00 |
| Exercise | Common Stock | 21,132 | $194.12 | $4.10M |
| Exercise | Common Stock | 12,429 | $208.44 | $2.59M |
| Sale | Common Stock F1 | 33,561 | $300.00 | $10.07M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 19,473 shares (Direct);
Common Stock — 31,596 shares (Direct);
Common Stock — 5,423 shares (Indirect, 2024 GRAT);
Common Stock — 10,780 shares (Indirect, 2025 GRAT);
Common Stock — 20,000 shares (Indirect, 2026 GRAT);
Common Stock — 155,611 shares (Indirect, By Trust);
Common Stock — 10,000 shares (Indirect, By Trust Held By Spouse)
Footnotes (1)
- F1. This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026.
Key Figures
Shares sold: 33,561 shares of Common Stock
Sale price: $300.00 per share
Options exercised at $194.12: 21,132 stock options
+5 more
8 metrics
Shares sold
33,561 shares of Common Stock
Sale on August 25, 2026 at $300.00 per share
Sale price
$300.00 per share
Price for 33,561 CRL shares sold on August 25, 2026
Options exercised at $194.12
21,132 stock options
Options to buy CRL common stock exercised on August 25, 2026
Options exercised at $208.44
12,429 stock options
Options to buy CRL common stock exercised on August 25, 2026
Indirect holdings – 2024 GRAT
5,423 shares of Common Stock
Indirect ownership through 2024 GRAT after transactions
Indirect holdings – 2025 GRAT
10,780 shares of Common Stock
Indirect ownership through 2025 GRAT after transactions
Indirect holdings – Trust
155,611 shares of Common Stock
Indirect ownership by trust after transactions
Indirect holdings – Spouse’s trust
10,000 shares of Common Stock
Indirect ownership by trust held by spouse after transactions
Key Terms
Rule 10b5-1 Trading Plan, Stock Options (Right to Buy, Grantor Retained Annuity Trust, transaction code S
4 terms
Rule 10b5-1 Trading Plan regulatory
"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Options (Right to Buy financial
"security_title": "Stock Options (Right to Buy)"
Grantor Retained Annuity Trust financial
"nature_of_ownership": "2024 GRAT"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
transaction code S regulatory
"transaction_code": "S","transaction_type": "non-derivative"
FAQ
What did CRL director James C. Foster report on this Form 4?
He reported exercising stock options for 33,561 shares of CHARLES RIVER LABORATORIES common stock and selling 33,561 shares on August 25, 2026, along with updated indirect holdings in various trusts and Grantor Retained Annuity Trusts.
What stock options did James C. Foster exercise in this CRL filing?
He exercised stock options on 21,132 shares with an exercise price of $194.12 per share and on 12,429 shares with an exercise price of $208.44 per share, receiving an equal number of CRL common shares on August 25, 2026.
Does this CRL Form 4 show net buying or selling activity?
It shows net selling activity. The transaction summary reports 33,561 shares exercised from options and an equal 33,561 shares sold, resulting in a net-sell share count of 33,561 for the reported buy/sell activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
